Search results for "cancer marker"

showing 6 items of 6 documents

A useful procedure for detection of polyamines in biological samples as a potential diagnostic tool in cancer diagnosis

2017

Abstract Background Polyamines present in human body are frequently considered as markers of occurrence of cancer. Therefore, the availability of simple and efficient method for determination of their level in body liquids and tissues is of some interest. Methods Supported liquid membrane technology coupled with HPLC seems to be an appropriate technique to follow the level of polyamines in human blood and urine. Thus, the membranes of two different geometries: flat sheet and hollow fiber were studied as a mean for separation and enrichment of studied polyamines from urine and tissue samples in order to prepare samples to be analyzed by HPLC. Conclusions Developed extraction systems offer an…

0301 basic medicineFlat sheetChromatographyHuman bloodsperminecadaverinecancer markersChemistryExtraction (chemistry)General Medicinelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensHigh-performance liquid chromatographylcsh:RC254-282supported liquid membranes03 medical and health sciences030104 developmental biology0302 clinical medicineMembraneBiochemistry030220 oncology & carcinogenesisspermidineputrescineApplied Cancer Research
researchProduct

Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications

2013

Cell to cell communication is essential for the coordination and proper organization of different cell types in multicellular systems. Cells exchange information through a multitude of mechanisms such as secreted growth factors and chemokines, small molecules (peptides, ions, bioactive lipids and nucleotides), cell-cell contact and the secretion of extracellular matrix components. Over the last few years, however, a considerable amount of experimental evidence has demonstrated the occurrence of a sophisticated method of cell communication based on the release of specialized membranous nano-sized vesicles termed exosomes. Exosome biogenesis involves the endosomal compartment, the multivesicu…

Cell typeCell signalingcancer markersEndosomeReviewexosomesBiologyCatalysislcsh:ChemistryInorganic ChemistryExtracellularexosomecell signalingSecretionPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopycancer microenvironmentVesicleOrganic ChemistryGeneral MedicineMicrovesiclesComputer Science ApplicationsCell biologylcsh:Biology (General)lcsh:QD1-999Signal transductionInternational Journal of Molecular Sciences
researchProduct

Molecular Fingerprints of Thyroid Cancer Cells by Using Library of Molecular Receptors Formed by N-Lipidated Peptides Immobilized on Cellulose

2018

This paper presents a novel diagnostic method using a library of molecular receptors to assess the composition of healthy and tumorous tissue samples. Molecular receptors were formed by self-organization of N-lipidated peptides attached in the regular fashion via aminophenylamino-1,3,5-triazine linkers to the surface of a cellulose plate. The library was cloned into multiple, identical copies. A new clone was used in each test. The binding process was monitored by staining the discs with Brilliant Black and quantitative color measure- ment was performed in 256-grade grayscale. Substantial differences in the composition of healthy and tumor samples were observed in most cases. The sharp diff…

Pharmacologycancer markersPharmaceutical Sciencemedicine.diseasechemistry.chemical_compoundchemical receptorchemistryBiochemistrymedicineimmobilized pep- tidesCelluloseReceptorsurface modificationmolecular mono-layerThyroid cancerActa Poloniae Pharmaceutica - Drug Research
researchProduct

Automated Cancer Marker Characterization in Human Plasma Using SUrface PLASMON Resonance in Array combined with Mass Spectrometry (SUPRA-MS)

2012

International audience; The combination of Surface Plasmon Resonance technology with Mass Spectrometry becomes a key method for the characterization of targeted proteins in the fields of diagnosis and functional proteomics. We demonstrated in this work the ability of our SPRi-chip to capture targeted protein in biological fluids and in situ analyze by MS and MS/MS modes through automated procedure to go beyond classical immunoassays. Here, we established a proof of concept of SUPRA-MS for the detection, the identification and the characterization of a potential breast cancer marker.

ProteomicsChemistry(all)Immuno-sensor[SDV.CAN]Life Sciences [q-bio]/CancerMass spectrometryProteomicsbiosensor01 natural sciencesMass Spectrometry[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health scienceschipSUPRA-MSSurface plasmon resonance[SPI.NANO]Engineering Sciences [physics]/Micro and nanotechnologies/Microelectronics030304 developmental biologyCancer marker0303 health sciencesChromatographyChemistryImmuno sensor010401 analytical chemistryGeneral MedicineBiomarkerSurface Plasmon Resonance0104 chemical sciences3. Good healthBiomarker (cell)Characterization (materials science)Human plasmaChemical Engineering(all)"Surface Plasmon Resonance[ SPI.NANO ] Engineering Sciences [physics]/Micro and nanotechnologies/MicroelectronicsBiosensorchip"
researchProduct

Cancer and the microbiome : potential applications as new tumor biomarker

2015

Abstract: Microbial communities that colonize in humans are collectively described as microbiome. According to conservative estimates, about 15% of all types of neoplasms are related to different infective agents. However, current knowledge is not sufficient to explain how the microbiome contributes to the growth and development of cancers. Large and thorough studies involving colonized, diverse and complex microbiome entities are required to identify microbiome as a potential cancer marker and to understand how the immune system is involved in response to pathogens. This article reviews the existing evidence supporting the enigmatic association of transformed microbiome with the developmen…

RiskComputational biologyBiologycancer biomarkerImmune systemcancer diagnosisNeoplasmstransformed microbiomemedicineBiomarkers TumorAnimalsHumansPharmacology (medical)Microbiomecancer biomarker; cancer diagnosis; cancer prevention; immunological modification; transformed microbiome; Animals; Biomarkers; Tumor; Humans; Neoplasms; Risk; Microbiota; Oncology; Pharmacology (medical)Cancer markercancer diagnosiimmunological modificationCancer preventionTumorcancer preventionAnimalMicrobiotaCancermedicine.diseaseBiomarkercancer biomarker; cancer diagnosis; cancer prevention; immunological modification; transformed microbiome; Animals; Biomarkers Tumor; Humans; Neoplasms; Risk; Microbiota; Oncology; Pharmacology (medical)OncologyImmunologyNeoplasmHuman medicineBiomarkersHumanExpert review of anticancer therapy
researchProduct

Tissue microarray technology in breast cancer subtyping

2008

breast cancerrintasyöpätissue microarray technologyimmunohistochemistrybreast carcinomacancer marker
researchProduct